Home › Ceres Wins $750K DARPA Grant to Develop Zika, Pathogens Tests

Ceres Wins $750K DARPA Grant to Develop Zika, Pathogens Tests

Feb 22, 2017

NEW YORK (GenomeWeb) – Ceres Nanoscience said today it has received a $750,000 award from the US Department of Defense's Defense Advanced Research Projects Agency (DARPA) to develop the company's Nanotrap technology for detection of Zika and other pathogens.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oct
10
Featured Webinar

Personalization of Oncology Pathways: Clinical Quality Initiatives Amid a Complex Molecular Landscape

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.

What's Popular?

In Molecular Diagnostics

  1. PGx Experts Encourage Greater Standardization of Tests to Improve Adoption, Patient Care

    Premium

  2. ACLA Expresses Concern Over FDA's Proposal for Regulating In Vitro Diagnostic Tests

  3. MBio Diagnostics Raises Additional $6M in Series B Funding Round

  4. Akonni Biosystems Scores $3M NIH Grant for POC Dx Platform, Drug-Resistant TB Assay

  5. Qiagen Names TSG Exclusive Commercial Partner in Africa

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.